Regenxbio Total Assets from 2010 to 2024

RGNX Stock

USD 9.92 0.09 0.90%

Regenxbio Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 487 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-12-31

Previous Quarter

569.4 M

Current Value

519.1 M

Quarterly Volatility

293.2 M

Yuan Drop

Covid

Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.

Check out the analysis of Regenxbio Correlation against competitors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Total Assets Growth Pattern

Below is the plot of the Total Assets of Regenxbio over the last few years. Total assets refers to the total amount of Regenxbio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Regenxbio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Regenxbio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 573.97 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Regenxbio Total Assets Regression Statistics

	Arithmetic Mean	357,621,987
	Geometric Mean	82,149,467
	Coefficient Of Variation	98.77
	Mean Deviation	300,620,786
	Median	221,380,000
	Standard Deviation	353,230,592
	Sample Variance	124771.9T
	Range	1.1B
	R-Value	0.83
	Mean Square Error	40775.6T
	R-Squared	0.70
	Significance	0.0001
	Slope	65,919,949
	Total Sum of Squares	1746805.9T

Regenxbio Total Assets History

	2024	487 M
	2023	574 M
	2022	833.3 M
	2021	1.1 B
	2020	708.2 M
	2019	497.9 M
	2018	543.8 M

Other Fundumenentals of Regenxbio

Intangibles To Total Assets

Regenxbio Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Capital Surpluse	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.96	0.75	-0.58	-0.54	0.71	0.84	0.89	0.96	0.53	-0.63	0.95	0.68	0.69	0.83	-0.17	0.73	0.89	0.92	0.85	-0.17	-0.17
Total Stockholder Equity	0.96		0.82	-0.55	-0.43	0.6	0.76	0.73	0.93	0.42	-0.67	0.96	0.69	0.7	0.87	-0.13	0.64	0.81	0.94	0.82	-0.13	-0.13
Current Deferred Revenue	0.75	0.82		-0.5	-0.17	0.34	0.69	0.5	0.7	0.14	-0.59	0.74	0.5	0.6	0.79	0.13	0.38	0.6	0.76	0.59	0.13	0.13
Net Debt	-0.58	-0.55	-0.5		-0.2	0.07	-0.53	-0.51	-0.61	0.26	0.29	-0.42	0.02	-0.3	-0.59	-0.4	0.02	-0.27	-0.49	-0.68	-0.4	-0.4
Retained Earnings	-0.54	-0.43	-0.17	-0.2		-0.93	-0.55	-0.63	-0.56	-0.97	0.48	-0.6	-0.66	-0.56	-0.09	0.8	-0.89	-0.73	-0.4	-0.41	0.8	0.8
Accounts Payable	0.71	0.6	0.34	0.07	-0.93		0.64	0.77	0.68	0.95	-0.49	0.7	0.74	0.56	0.34	-0.64	0.94	0.84	0.6	0.53	-0.64	-0.64
Net Receivables	0.84	0.76	0.69	-0.53	-0.55	0.64		0.83	0.9	0.49	-0.5	0.78	0.65	0.59	0.51	-0.18	0.6	0.81	0.73	0.86	-0.18	-0.18
Total Liab	0.89	0.73	0.5	-0.51	-0.63	0.77	0.83		0.86	0.62	-0.44	0.77	0.53	0.55	0.61	-0.21	0.77	0.88	0.72	0.75	-0.21	-0.21
Total Current Assets	0.96	0.93	0.7	-0.61	-0.56	0.68	0.9	0.86		0.52	-0.67	0.92	0.72	0.74	0.69	-0.18	0.66	0.86	0.85	0.91	-0.18	-0.18
Short Term Debt	0.53	0.42	0.14	0.26	-0.97	0.95	0.49	0.62	0.52		-0.48	0.57	0.65	0.46	0.14	-0.79	0.91	0.71	0.42	0.37	-0.79	-0.79
Common Stock	-0.63	-0.67	-0.59	0.29	0.48	-0.49	-0.5	-0.44	-0.67	-0.48		-0.69	-0.54	-0.69	-0.45	0.22	-0.44	-0.53	-0.49	-0.49	0.22	0.22
Net Tangible Assets	0.95	0.96	0.74	-0.42	-0.6	0.7	0.78	0.77	0.92	0.57	-0.69		0.76	0.74	0.78	-0.27	0.75	0.91	0.88	0.75	-0.27	-0.27
Short Term Investments	0.68	0.69	0.5	0.02	-0.66	0.74	0.65	0.53	0.72	0.65	-0.54	0.76		0.68	0.36	-0.3	0.63	0.8	0.62	0.55	-0.3	-0.3
Deferred Long Term Liab	0.69	0.7	0.6	-0.3	-0.56	0.56	0.59	0.55	0.74	0.46	-0.69	0.74	0.68		0.43	-0.18	0.51	0.68	0.55	0.55	-0.18	-0.18
Long Term Investments	0.83	0.87	0.79	-0.59	-0.09	0.34	0.51	0.61	0.69	0.14	-0.45	0.78	0.36	0.43		0.14	0.46	0.61	0.85	0.58	0.14	0.14
Short Long Term Debt	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14		-0.69	-0.32	-0.22	-0.2	1.0	1.0
Property Plant Equipment	0.73	0.64	0.38	0.02	-0.89	0.94	0.6	0.77	0.66	0.91	-0.44	0.75	0.63	0.51	0.46	-0.69		0.85	0.68	0.52	-0.69	-0.69
Capital Surpluse	0.89	0.81	0.6	-0.27	-0.73	0.84	0.81	0.88	0.86	0.71	-0.53	0.91	0.8	0.68	0.61	-0.32	0.85		0.77	0.67	-0.32	-0.32
Net Invested Capital	0.92	0.94	0.76	-0.49	-0.4	0.6	0.73	0.72	0.85	0.42	-0.49	0.88	0.62	0.55	0.85	-0.22	0.68	0.77		0.84	-0.22	-0.22
Net Working Capital	0.85	0.82	0.59	-0.68	-0.41	0.53	0.86	0.75	0.91	0.37	-0.49	0.75	0.55	0.55	0.58	-0.2	0.52	0.67	0.84		-0.2	-0.2
Long Term Debt Total	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2		1.0
Capital Stock	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2	1.0

Click cells to compare fundamentals

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	574 M	487 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC